Experience the Future of Cataract Surgery

The ALLY® Adaptive Cataract Treatment System empowers you to provide premium cataract experiences with optimal treatment outcomes and efficiencies to more patients, enabling you to seize new opportunities and help your practice thrive.

Save More With ALLY’s Efficiencies

The efficiencies of the ALLY System make it possible to save time and overhead and perform more procedures, all while reducing energy delivered to the eye.

Save up to

8 minutes

per case

compared to other femto
cataract systems1,2

Up to

27% reduction

in mean phaco time

compared to manual cataract surgery
(1.73 sec vs 2.38 sec)3,4

Surgeons performed

15% more

FLACS procedures*

after switching to the
ALLY Laser System

Explore ALLY’s Systemwide Efficiencies

Deliver Premium Outcomes

ALLY’s proprietary technology delivers a new level of precision and accuracy that makes it possible to provide premium outcomes for premium cases, including low- and high-level astigmatism management.

Up to


within 0.50 D

for patients treated with a toric
IOL guided by IntelliAxis®5-8

Up to


within 0.50 D

for patients treated with
arcuate incisions9,10

Discover the Precision and Accuracy of the ALLY System

Experience Adaptability Like Never Before

Adaptive Intelligence™ guides and optimizes every step of cataract surgery for faster procedures, unsurpassed precision, and the ultimate FLACS experience.
  • System adapts to any space and surgical environment
  • Iris registration adjusts for cyclorotation
  • Customzed fragmentation patterns based on density categorization
Learn About the Benefits of ALLY’s Adaptability

Provide the Premium Experience That Patients Expect

ALLY allows you to deliver a premium cataract experience to as many patients as possible.
  • 1 room sterile procedure simplifies the patient experience
  • 51 minute patient time savings in feeder model (ALLY vs. LenSx)1
  • Significantly lower endothelial cell loss at 6 months11
  • LASIK-like outcomes5-10
Find Out How ALLY Delivers a Next-Level Experience

*1H 2023 procedure sales as compared to 1H 2022 procedure sales from LENSAR Laser System users who have added or replaced their laser system with an ALLY System.


  1. Data on file, LENSAR, Inc. 2023.
  2. Visco D. Comparison of full sterile and nonsterile FLACS procedures in an OR environment. Presented at: Cedars Aspens Annual Meeting; December 8-10, 2022; Scottsdale, AZ.
  3. Effectiveness of Femtosecond Laser-assisted Cataract Surgery and Manual Phacoemulsification during the Learning Curve of Fellows in Training (ASCRS 2023).
  4. Robert J. Weinstock, MD. Prospective, randomized, contralateral eye study of femtosecond laser-assisted cataract surgery and manual phacoemulsification (ASCRS 2023).
  5. Visco DM. Iris registration-guided femtosecond laser-assisted capsular marks to guide toric IOL alignment during cataract surgery. Paper presented at: ASCRS-ASOA Annual Meeting: May 3 – 7, 2019; San Diego, CA.
  6. Visco D, Hill W, McKee Y. Safety and effectiveness of a novel femtosecond laser-assisted capsular marking system for the alignment of toric IOLs: a prospective study. Presented at: European Society of Cataract and Refractive Surgeons Congress: September 14 – 18, 2019; Paris, France.
  7. Stephenson PDG. Femtosecond laser-assisted capsular marks and ORA to guide toric IOL alignment during cataract surgery. Presented at: American Society of Cataract and Refractive Surgery Annual Meeting: May 3 – 7, 2019; San Diego, CA.
  8. Stephenson PDG. Validation of iris-registration-guided femtosecond laser capsular marks to guide toric IOL alignment with intraoperative aberrometry. Presented at: American Society of Cataract and Refractive Surgery Annual Meeting: May 5 – 8, 2023; San Diego, CA.
  9. Visco DM. Astigmatism management with arcuate incisions created with a novel, dual pulse femtosecond laser system. Presented at: American Society of Cataract and Refractive Surgery Annual Meeting: May 5 – 8, 2023; San Diego, CA.
  10. Visco DM, Bedi R, Packer M. Femtosecond laser-assisted arcuate keratotomy at the time of cataract surgery for the management of preexisting astigmatism. J Cataract Refract Surg. 2019;45(12):1762-1769.
  11. Brar S. Safety and endothelial cell density following phaco and FLACS with customized fragmentation patterns in dense cataracts. Presented at ASCRS Annual Meeting: San Diego,CA; May5-8, 2023.

Discover how ALLY can support your practice.

© 2024 LENSAR, Inc. All rights reserved. LENSAR, the LENSAR logo, Streamline, IntelliAxis, IntelliAxis Refractive Capsulorhexis, ALLY Adaptive Cataract Treatment System, and the ALLY Adaptive Cataract Treatment System logo are registered trademarks and the LENSAR Cataract Laser with Augmented Reality logo, Intelligent Incisions, Augmented Reality, and Adaptive Intelligence are trademarks of LENSAR, Inc. All other trademarks are their owners. 50-00503-000 Rev. B 04/24